Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Stability, Robustness and Usability of the Dreem 3 System for EEG Sleep Monitoring in the Home Setting, in an Insomnia Population.

NCT05611099 is registered in ClinicalTrials.gov with Dreem as lead sponsor.

NCT NCT05611099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05611099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Stability, Robustness and Usability of the Dreem 3 System for EEG Sleep Monitoring in the Home Setting, in an Insomnia Population.
Lead sponsor
Dreem
Phase
Not applicable
Overall status
Completed
Start date
August 15, 2022
Completion date
November 5, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, secondary, sleep, sleep disturbance, sleep initiation and maintenance disorders